Conditional survival after surgical resection of primary retroperitoneal tumors: a population-based study
- PMID: 33472625
- PMCID: PMC7816497
- DOI: 10.1186/s12935-021-01751-z
Conditional survival after surgical resection of primary retroperitoneal tumors: a population-based study
Abstract
Background: The purpose of this study was to assess conditional survival (CS) after resection of primary retroperitoneal tumors (RPTs).
Methods: The data of 1594 patients with primary RPTs who underwent surgery between 2004 and 2016 were retrieved from the Surveillance Epidemiology and End Results (SEER) database. Multivariate Cox analysis was used to identify prognostic factors affecting overall survival (OS) and cancer-specific survival (CSS). CS was used to calculate the probability of survival for an additional 3 years after the patient had survived x years, according to the formulas: COS3 = OS (x + 3) /OS (x) and CCSS3 = CSS (x + 3)/CSS (x).
Results: The 1-, 3-, and 5-year OS rates of all patients were 89.8, 71.8, and 60.8%, while the 1-, 3-, and 5-year CSS rates were 91.9, 77.1, and 67.8%, respectively. Age, sex, FNCLCC grade, size, multifocality, histology, and chemotherapy were independent prognostic factors for OS and CSS. Among patients who survived for 1, 3, and 5 years, the COS3 rates were 72.9, 77.9, and 79.3%, and the CCSS3 rates were 78.1, 82.7, and 85.8%, respectively. Patients with poor clinicopathological characteristics achieved greater improvements in COS3 and CCSS3 rates, and the survival gaps between OS and COS3, as well as CSS and CCSS3 were more obvious.
Conclusion: Postoperative CS of RPTs was dynamic and increased over time. CS increased more significantly in patients with poor clinicopathological characteristics.
Keywords: Conditional survival; Dynamic assessment; Primary retroperitoneal tumors; Prognosis.
Conflict of interest statement
The authors report no competing interest in this study.
Figures
Similar articles
-
Conditional Survival of Advanced Epithelial Ovarian Cancer: A Real-World Data Retrospective Cohort Study From the SEER Database.Front Med (Lausanne). 2021 Nov 23;8:756401. doi: 10.3389/fmed.2021.756401. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34888325 Free PMC article.
-
Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population-based study.Cancer Med. 2018 Nov;7(11):5359-5369. doi: 10.1002/cam4.1683. Epub 2018 Oct 11. Cancer Med. 2018. PMID: 30311450 Free PMC article.
-
Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.Orthop Surg. 2019 Oct;11(5):801-810. doi: 10.1111/os.12521. Orthop Surg. 2019. PMID: 31663279 Free PMC article.
-
Conditional survival probability of distant-metastatic hepatocellular carcinoma: A population-based study.World J Gastrointest Oncol. 2023 Nov 15;15(11):1874-1890. doi: 10.4251/wjgo.v15.i11.1874. World J Gastrointest Oncol. 2023. PMID: 38077643 Free PMC article.
-
[Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):85-93. Zhonghua Wei Chang Wai Ke Za Zhi. 2019. PMID: 30703799 Chinese.
Cited by
-
Conditional Survival of Advanced Epithelial Ovarian Cancer: A Real-World Data Retrospective Cohort Study From the SEER Database.Front Med (Lausanne). 2021 Nov 23;8:756401. doi: 10.3389/fmed.2021.756401. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34888325 Free PMC article.
References
-
- Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol. 2015;22(1):256–263. - PubMed
-
- Toulmonde M, Bonvalot S, Ray-Coquard I, et al. Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol. 2014;25(3):730–734. doi: 10.1093/annonc/mdt576. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
